73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A: Study

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A: Study

by Higher Education PressCoactivator-associated arginine methyltransferase 1 (CARM1) was recruited by hypoxia-inducible factor 1 subunit alpha (HIF1A) to form a complex and transactivate CDK4 and HIF1

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A: Study

by Higher Education PressCoactivator-associated arginine methyltransferase 1 (CARM1) was recruited by hypoxia-inducible factor 1 subunit alpha (HIF1A) to form a complex and transactivate CDK4 and HIF1
High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t
Risk of cervical cancer found to be twice as high in women with mental illness

Risk of cervical cancer found to be twice as high in women with mental illness

byKarolinska InstitutetHighgrade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progre

Risk of cervical cancer found to be twice as high in women with mental illness

byKarolinska InstitutetHighgrade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progre
Simple laser treatments may prevent nonmelanoma skin cancer

Simple laser treatments may prevent nonmelanoma skin cancer

by Katie Marquedant,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainNew research indicates that simple laser treatments to the skin may help to prevent the development of basal ce

Simple laser treatments may prevent nonmelanoma skin cancer

by Katie Marquedant,Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainNew research indicates that simple laser treatments to the skin may help to prevent the development of basal ce
A case for routine evaluation of HER2 expression in ductal carcinoma in situ

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde
Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

by Cindy Krischer GoodmanCredit: Unsplash/CC0 Public DomainBroward County, Florida's rate of advanced breast cancer exceeds the state and national average, and researchers want to learn why.Could

Something in the water? Researchers studying large number of late-stage breast cancer cases in Florida county

by Cindy Krischer GoodmanCredit: Unsplash/CC0 Public DomainBroward County, Florida's rate of advanced breast cancer exceeds the state and national average, and researchers want to learn why.Could
Ultrasensitive blood test detects 'pan-cancer' biomarker

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit
Liver cancer: How liver cells go astray

Liver cancer: How liver cells go astray

byUniversity of BaselOne of the main causes of liver cancer is excessive alcohol consumption. Credit: Biozentrum, University of BaselThe causes of liver cancer are manifold. In addition to metab

Liver cancer: How liver cells go astray

byUniversity of BaselOne of the main causes of liver cancer is excessive alcohol consumption. Credit: Biozentrum, University of BaselThe causes of liver cancer are manifold. In addition to metab
A blood test that screens for multiple cancers at once promises to boost early detection

A blood test that screens for multiple cancers at once promises to boost early detection

by Colin Pritchard,The ConversationDNA contains molecular patterns that indicate where in the body it came from. Credit:CNX OpenStax/Wikimedia Commons,CC BYDetecting cancer early bef

A blood test that screens for multiple cancers at once promises to boost early detection

by Colin Pritchard,The ConversationDNA contains molecular patterns that indicate where in the body it came from. Credit:CNX OpenStax/Wikimedia Commons,CC BYDetecting cancer early bef
Standard pathology tests outperform molecular subtyping in bladder cancer

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers
FDA approves engineered cell therapy for treating rare sarcoma

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami